SciMed Biotech Podcast with Bruce Bloom
The Generalist Guide to Biotech Startups and Genetic Readthrough
In this episode of the SciMed Biotech Podcast, SciMed President Adam Stasio sits down with Dr. Bruce Bloom, the founder and CEO of Fortuity Pharma, to explore the unique intersection of for-profit biotechs and rare disease nonprofits. Dr. Bloom shares his unconventional career path from dentistry and malpractice law to biotech leadership, detailing his "broad but not deep" management playbook for scaling small startup teams. The conversation dives into the complex economics of drug repurposing and the underlying science of translational readthrough therapies for genetic nonsense mutations. Finally, Dr. Bloom previews Fortuity Pharma’s bootstrapped mission to develop a localized eye-drop therapy aimed at preventing blindness in children with the rare disease aniridia.
